4582 SymBio Pharmaceuticals
- 238
- -8-3.25%
SymBio Pharmaceuticals News
SymBio Pharmaceuticals: Confirmatory letter.
SymBio Pharmaceuticals: Semiannual Report - 20th Period (01/01/2024 - 12/31/2024)
SymBio Pharmaceuticals: Short message of the consolidated financial statements for the second quarter of the fiscal year ending December 2024 [Japan Standards]
SymBio Pharmaceuticals: Quarterly Report - 20th Quarter 1 (2024/01/01 - 2024/03/31)
SymBio Pharmaceuticals: Confirmation letter
SymBio Pharmaceuticals: Notice regarding revisions to the full-year earnings forecast for the fiscal year ending 2024/12
SymBio Pharmaceuticals: Summary of Financial Results for the 1st Quarter Ending 2024/12 [Japanese GAAP] (Consolidated)
SymBio Pharmaceuticals: Interim Report of Corrections
SymBio Pharmaceuticals: Extraordinary Report
SymBio Pharmaceuticals: Extraordinary Report
SymBio Pharmaceuticals: Confirmation letter
SymBio Pharmaceuticals: Financial Report - 19th Term (2023/01/01 - 2023/12/31)
SymBio Pharmaceuticals: Notice regarding the recording of impairment losses and differences between full-year consolidated earnings forecasts and actual values
SymBio Pharmaceuticals: Summary of Financial Results for the Fiscal Year Ending 2023/12 [Japanese GAAP] (Consolidated)
SymBio Pharmaceuticals: Confirmation letter
SymBio Pharmaceuticals: Quarterly Report - 19th Third Quarter (2023/07/01 - 2023/09/30)
SymBio Pharmaceuticals: Notice Concerning Revision of Full-Year Earnings Forecasts for the Fiscal Year Ending 2023/12 and Dissolution of Deferred Tax Assets
SymBio Pharmaceuticals: Summary of financial results for the 3rd quarter of the fiscal year ending December 31, 2023 [Japanese GAAP] (Consolidated)
SymBio Pharmaceuticals: Confirmation letter
SymBio Pharmaceuticals: Quarterly Report - Second Quarter 19th (2023/04/01 - 2023/06/30)
Analysis
Price Target
No Data
